PMID: 9658984Jul 11, 1998Paper

Theophylline in treatment of bronchial obstructive diseases

Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
B Rogala

Abstract

The article is the review of the data from literature concerning the new role of theophilline in the management of asthma and chronic bronchoobturative pulmonary disease. Theophilline has been widely used to treat asthma and COPD patients worldwide and is classified as a bronchodilatator, although there is increasing evidence that it has antiinflammatory activity and enhances immunomodulatory effects. The latter is therapeutically relevant to markedly lower serum concentration (even < 10 micrograms/ml) than this required for bronchodilatation. That is particularly clinically important because significant adverse effects have been seen only in the case of doses greater than 10 micrograms/ml.

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
W Pierzchała, M Farnik-Brodzińska
American Journal of Respiratory and Critical Care Medicine
Peter J Barnes
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Angélica Florípedes do AmaralJosé Antônio Baddini Martinez
© 2022 Meta ULC. All rights reserved